Literature DB >> 22585768

Lipid profiles of children with Down syndrome compared with their siblings.

Tahira Adelekan1, Sheela Magge, Justine Shults, Virginia Stallings, Nicolas Stettler.   

Abstract

OBJECTIVES: Our objective was to compare serum lipid profiles, total cholesterol (TC), low-density lipoprotein (LDL), triglycerides (TG), and high-density lipoprotein (HDL) between children with Down syndrome (DS) and their non-DS siblings. We hypothesized that the children with DS would have higher TC, LDL, and TG and lower HDL. The secondary aim was to explore if the difference in lipid profiles could be explained by differences in weight status.
METHODS: This was a cross-sectional study. Fasting lipid profile was obtained from 27 children with DS and 31 siblings between 4 and 10 years of age with no severe comorbidities (heart disease, cancer, hypothyroidism, diabetes, or obesity). BMI was calculated and BMI z scores were used to account for differences in BMI throughout childhood.
RESULTS: Children with DS had higher TC (difference, 11.2 mg/dL; 95% confidence interval: 2.5-19.9; P = .01), LDL (12.8 mg/dL; 7.2-18.4; P < .001), TG (33.6 mg/dL; 11.1-56.1; P = .003), and lower HDL (-7.6 mg/dL; -12.1 to -3.0; P = .001) after adjustment for race, gender, age, and ethnicity. Results remained significant after additional adjustment for BMI z score: TC (14.9 mg/dL; 4.9-24.9; P = .003), LDL (16.6 mg/dL; 10.1-23.2; P < .001), TG (32.7 mg/dL; 7.7-57.7; P = .01), and lower HDL (-6.4 mg/dL; -12.2 to -0.7; P = .03).
CONCLUSIONS: Children with DS have less favorable lipid profiles than their siblings independent of weight status. These findings may have important implications for the screening and treatment of this large population at increased risk for ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585768      PMCID: PMC3362900          DOI: 10.1542/peds.2011-1262

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  30 in total

Review 1.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

2.  Hyperlipidaemia in patients with Down's syndrome.

Authors:  Y Nishida; I Akaoka; T Nishizawa; M Maruki; K Maruki
Journal:  Atherosclerosis       Date:  1977-03       Impact factor: 5.162

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  The changing survival profile of people with Down's syndrome: implications for genetic counselling.

Authors:  E J Glasson; S G Sullivan; R Hussain; B A Petterson; P D Montgomery; A H Bittles
Journal:  Clin Genet       Date:  2002-11       Impact factor: 4.438

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  Health supervision for children with Down syndrome.

Authors:  Marilyn J Bull
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

Review 7.  Clinical significance, pathogenesis, and management of postprandial hyperglycemia.

Authors:  John E Gerich
Journal:  Arch Intern Med       Date:  2003-06-09

8.  Down's syndrome: an atheroma-free model?

Authors:  J C Murdoch; J C Rodger; S S Rao; C D Fletcher; M G Dunnigan
Journal:  Br Med J       Date:  1977-07-23

9.  Mortality and cancer incidence among individuals with Down syndrome.

Authors:  Deirdre A Hill; Gloria Gridley; Sven Cnattingius; Lene Mellemkjaer; Martha Linet; Hans-Olof Adami; Jorgen H Olsen; Olof Nyren; Joseph F Fraumeni
Journal:  Arch Intern Med       Date:  2003-03-24

10.  New cross sectional stature, weight, and head circumference references for Down's syndrome in the UK and Republic of Ireland.

Authors:  M E Styles; T J Cole; J Dennis; M A Preece
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

View more
  17 in total

1.  Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

Authors:  Troy T Rohn; Katie L McCarty; Julia E Love; Elizabeth Head
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-12-08

2.  Cardiometabolic Risk and Body Composition in Youth With Down Syndrome.

Authors:  Sheela N Magge; Babette S Zemel; Mary E Pipan; Samuel S Gidding; Andrea Kelly
Journal:  Pediatrics       Date:  2019-07-17       Impact factor: 7.124

3.  JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome.

Authors:  Kathryn D Tuttle; Katherine A Waugh; Paula Araya; Ross Minter; David J Orlicky; Michael Ludwig; Zdenek Andrysik; Matthew A Burchill; Beth A J Tamburini; Colin Sempeck; Keith Smith; Ross Granrath; Dayna Tracy; Jessica Baxter; Joaquin M Espinosa; Kelly D Sullivan
Journal:  Cell Rep       Date:  2020-11-17       Impact factor: 9.423

4.  The contribution of the citrate pathway to oxidative stress in Down syndrome.

Authors:  Paolo Convertini; Alessio Menga; Generoso Andria; Iris Scala; Anna Santarsiero; Maria A Castiglione Morelli; Vito Iacobazzi; Vittoria Infantino
Journal:  Immunology       Date:  2016-10-03       Impact factor: 7.397

5.  Effects of two programs of exercise on body composition of adolescents with Down syndrome.

Authors:  Bruna Barboza Seron; Renan Alvarenga C Silva; Márcia Greguol
Journal:  Rev Paul Pediatr       Date:  2014-03

6.  A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome.

Authors:  Diego Real de Asua; Pedro Parra; Ramón Costa; Fernando Moldenhauer; Carmen Suarez
Journal:  Diabetes Metab J       Date:  2014-12-15       Impact factor: 5.376

Review 7.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

8.  Evaluation of biochemical and hematological parameters in adults with Down syndrome.

Authors:  David de Gonzalo-Calvo; Isabel Barroeta; Madalina Nicoleta Nan; José Rives; Diana Garzón; María Carmona-Iragui; Bessy Benejam; Laura Videla; Susana Fernández; Miren Altuna; Sílvia Valldeneu; Rafael Blesa; Alberto Lleó; Francisco Blanco-Vaca; Juan Fortea; Mireia Tondo
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

9.  Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome.

Authors:  Lara R DeRuisseau; Candace N Receno; Kevin S Heffernan; Caitlin M Cunningham
Journal:  Physiol Rep       Date:  2019-09

10.  Opportunities, barriers, and recommendations in down syndrome research.

Authors:  James A Hendrix; Angelika Amon; Leonard Abbeduto; Stamatis Agiovlasitis; Tarek Alsaied; Heather A Anderson; Lisa J Bain; Nicole Baumer; Anita Bhattacharyya; Dusan Bogunovic; Kelly N Botteron; George Capone; Priya Chandan; Isabelle Chase; Brian Chicoine; Cécile Cieuta-Walti; Lara R DeRuisseau; Sophie Durand; Anna Esbensen; Juan Fortea; Sandra Giménez; Ann-Charlotte Granholm; Laura J Hahn; Elizabeth Head; Hampus Hillerstrom; Lisa M Jacola; Matthew P Janicki; Joan M Jasien; Angela R Kamer; Raymond D Kent; Bernard Khor; Jeanne B Lawrence; Catherine Lemonnier; Amy Feldman Lewanda; William Mobley; Paul E Moore; Linda Pollak Nelson; Nicolas M Oreskovic; Ricardo S Osorio; David Patterson; Sonja A Rasmussen; Roger H Reeves; Nancy Roizen; Stephanie Santoro; Stephanie L Sherman; Nasreen Talib; Ignacio E Tapia; Kyle M Walsh; Steven F Warren; A Nicole White; Guang William Wong; John S Yi
Journal:  Transl Sci Rare Dis       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.